Panelists discuss that shifting talquetamab dosing from weekly to every 2 weeks improves response durability and patient ...

The FDA has granted accelerated approval to dordaviprone for use in adult and pediatric patients with H3 K27M-mutated diffuse midline glioma.

Cancer survivors, particularly men, in physically demanding jobs often face pressure to keep working during treatment, says ...

For patients with HR-positive breast cancer, adverse effects vary by CDK4/6 inhibitor, says Courtney Moore, APRN, FNP-C, OCN.

C, CNS, explained that understanding a patient’s emotional needs can help educate them on treatment adherence.

Hope S. Rugo, MD, FASCO, outlined the top considerations for nurses managing toxicities related to PI3K and AKT inhibitors in ...

Panelists discuss City of Hope’s collaborative partnership with community physicians, emphasizing expert evaluation at ...

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T-cell engagers, ...

Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple ...

Nurses should be familiar with PET scan protocol and what to ask patients with lung and bone cancers before administering ...

New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.

Explore essential mental health support strategies for older adults with cancer, addressing grief, community resources, and ...